USPH Q3 revenue $150M (+7.5%); adj. EBITDA $18.6M (+9.4%); GAAP EPS $0.51

U S PHYSICAL THERAPY INC /NV

2023-Q3 EPS reported $1.72 revenue$450,001,000

Total net revenue of $150M, up 7.5% YoY; net patient revenue from PT ops up 9.0% to $127.2M.
Adjusted EBITDA of $18.6M, up $1.6M from $17.0M in prior-year quarter.
GAAP net income attributable to USPH of $9.3M ($0.51 diluted EPS) vs $9.6M ($0.72) in Q3 2022.
Record-high third-quarter patient volume: average 29.7 visits per clinic per day, total visits up 10.8%.
Quarterly dividend of $0.43 per share declared; full-year Adjusted EBITDA guidance at $75M-$80M.

item 2.02 item 8.01 item 9.01

Key facts

Extracted from this filing and checked against the source text.

Earnings Releases SEC 8-K Item 2.02 confidence 0.95

U S PHYSICAL THERAPY INC /NV updated its three and nine months ended September 30, 2023 guidance (reaffirmed).

Period: three and nine months ended September 30, 2023
Guidance: reaffirmed
Result: reported results

Exact text from the filing

reported results for the three and nine months ended September 30, 2023.

View on SEC.gov

31 earnings releases filed in the last 30 days. Browse all earnings releases →

U S PHYSICAL THERAPY INC /NV filing history →

Source: SEC EDGAR

accession 0000885978-23-000041

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.